How it works
IGF-1 is the downstream signal of growth hormone that drives tissue growth. The LR3 modification extends its half-life and reduces binding to carrier proteins, so more stays active — a potent anabolic signal.
The evidence
There's a well-defined mechanism and strong preclinical rationale for muscle growth, but essentially no human clinical data for the physique uses it's marketed for. The gap between animal promise and human proof is wide.
Safety
Two serious concerns stand out: effects on blood glucose regulation (IGF-1 has insulin-like actions) and the theoretical risk of accelerating growth of existing tumors, since IGF-1 is a growth signal. These are reasons for real caution.
FAQ
No — it's the downstream growth factor itself, in a long-acting form, rather than the hormone that triggers it.
IGF-1 promotes cell growth, so raising it is theorized to potentially accelerate any existing cancer — a reason experts urge caution.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
- Emerging anabolic/regenerative peptides: mechanisms & evidence review
- Peptides for bodybuilding: research-based guide (PeptideDeck)
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Reviewed by Remy — part of the PepConnection crew.